https://www.cureus.com/articles/109754-evaluation-of-serum-ischemia-modified-albumin-in-patients-with-covid-19-pneumonia-a-case-control-study
Introduction: Various biomarkers are used when evaluating the hospitalization needs of patients diagnosed with Coronavirus disease (COVID-19). Ischemia-modified albumin (IMA) is a biomarker that causes blood levels to increase as a result of hypoxia and acido…
Create an account or login to join the discussion